Insider Trading April 10, 2026 07:29 PM

Photronics CEO Disposes of $5.2M in Stock as Shares Near Yearly High

George Macricostas sold 120,194 shares on April 8, 2026; company posts fiscal Q1 beat and readies new mask writer in Korea

By Jordan Park PLAB
Photronics CEO Disposes of $5.2M in Stock as Shares Near Yearly High
PLAB

Photronics Inc. Chief Executive George Macricostas reported the sale of 120,194 shares on April 8, 2026, in a Form 4 filing, generating $5,203,717. The transactions occurred in three tranches at prices between $42.90 and $43.28. The company recently reported fiscal Q1 2026 results that beat analyst estimates and announced a new mask writer to be installed at its Korea facility in fiscal Q2 2026.

Key Points

  • CEO George Macricostas sold 120,194 shares on April 8, 2026, for $5,203,717 in proceeds.
  • Photronics beat fiscal Q1 2026 EPS and revenue estimates and will install a new mask writer at its Korea facility in fiscal Q2 2026.
  • Shares are near a 52-week high after a 153% one-year gain; InvestingPro data flags PLAB as overvalued relative to Fair Value.

Sale details and holdings

Photronics Inc (NASDAQ: PLAB) CEO George Macricostas disclosed the sale of 120,194 company shares on April 8, 2026, in a Form 4 filed with the Securities and Exchange Commission. The three transactions together produced proceeds of $5,203,717, with executed prices spanning $42.90 to $43.28 per share. The breakdown of the trades was 6,500 shares sold at $43.27, 5,500 shares at $43.28 and 109,194 shares at $42.90. After completing these sales, Macricostas retains direct ownership of 334,068 Photronics shares.

Market context

The stock is trading close to its 52-week high of $45.92 and has moved substantially from its 52-week low of $16.59. Over the last 12 months the shares have returned roughly 153%, with a latest quoted price of $44.90 and a market capitalization of $2.62 billion. According to InvestingPro data, PLAB appears overvalued relative to its Fair Value analysis - a finding that the InvestingPro data suggests may provide context for the timing of the CEO’s sales. Investors seeking deeper valuation work can access detailed insights and additional InvestingPro Tips for PLAB through the platform’s Pro Research Report.

Recent financial results and operational updates

Photronics reported fiscal Q1 2026 earnings that exceeded analyst expectations. The company posted EPS of $0.61 versus the forecasted $0.5267, representing a 15.82% surprise to the upside. Revenue for the quarter reached $225.07 million, topping the anticipated $220.83 million, a variance of 1.92% above estimates.

Operationally, Photronics said it will install a new mask writer at its Korea facility in fiscal Q2 2026. The company indicated the equipment is intended to bolster production of AMOLED photomasks, with the objective of improving stability and resolution for those products.

Analyst coverage and governance actions

Craig-Hallum adjusted its price target on Photronics shares to $48 from $42 while maintaining a Buy rating. The firm highlighted Photronics’ position as semiconductor manufacturers increasingly outsource photomask production. At the company’s annual meeting, shareholders elected eight directors and approved both the auditor and executive compensation.

What this means and limitations of available information

The Form 4 filing documents the sale and the company’s recent operating performance is publicly reported; however, disclosures do not specify any personal rationale for the CEO’s transactions. The InvestingPro Fair Value assessment is cited as context in available data but does not, in itself, explain insider activity. Readers should note those information limits when interpreting the transaction alongside the company’s financial and operational updates.


Key points

  • CEO George Macricostas sold 120,194 shares on April 8, 2026, generating $5,203,717 across three trades.
  • Photronics beat fiscal Q1 2026 EPS and revenue estimates and plans to install a new mask writer at its Korea facility in fiscal Q2 2026.
  • Shares have risen about 153% over the past year and trade near their 52-week high; InvestingPro data flags PLAB as overvalued relative to Fair Value analysis.

Risks and uncertainties

  • Insider sales are disclosed but the Form 4 does not state personal motives, leaving interpretation of the transaction open.
  • Valuation assessments such as InvestingPro’s Fair Value analysis indicate potential overvaluation, which may affect investor sentiment and market dynamics.
  • Operational timing for the new mask writer is projected for fiscal Q2 2026; any delays or implementation issues could influence product output related to AMOLED photomasks.

Risks

  • The Form 4 filing records the sale but does not disclose the CEO’s personal reasons, leaving interpretation of the transaction unclear.
  • InvestingPro’s Fair Value assessment suggests potential overvaluation, which could impact investor reactions to insider transactions.
  • The planned Korea mask writer installation is scheduled for fiscal Q2 2026; delays or issues in deployment could affect AMOLED photomask production targets.

More from Insider Trading

Indie Semiconductor CFO Disposes of $154,560 in INDI Shares; Exercises 100,000 Options Apr 10, 2026 Apogee Therapeutics CEO Disposes $1.65M in Shares as Stock Nears 52-Week High Apr 10, 2026 Spire Global CTO Disposes $108.8K in Stock as Company Advances Satellite and Data Initiatives Apr 10, 2026 Framework Ventures IV Increases Stake in Better Home & Finance with $1.79M Purchase Apr 10, 2026 Fermi CFO Sells $3.9M in Stock as Company Faces Mixed Analyst Views After Q4 Loss Apr 10, 2026